Research map: Immuntherapie und Zelltherapie bei Diabetes mellitus Typ 1

Back to the article

Papers in this map

  1. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025 · Nuha A. ElSayed · 2024 · 1318 citations · Cited by this paper
  2. Lungentumor bei einer 68‑jährigen Patientin – Mimikry eines Bronchialkarzinoms · 2026 · Related
  3. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes · Kevan C. Herold · 2019 · 1182 citations · Cited by this paper
  4. Symptombelastung bei chronischer Nierenerkrankung – nephrologische Einschätzung im Vergleich zur Betroffenenperspektive (SOMA.CK-Studie) · 2026 · Related
  5. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function · Mark D. Pescovitz · 2009 · 1093 citations · Cited by this paper
  6. Personalisierte Arzneimitteltherapie des kolorektalen Karzinoms · 2026 · Related
  7. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient · Shusen Wang · 2024 · 277 citations · Cited by this paper
  8. Kaliumsubstitution – ist der Ersatz von natrium- durch kaliumhaltige Speisesalze sinnvoll? · 2026 · Related
  9. Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes · Teresa Quattrin · 2020 · 260 citations · Cited by this paper
  10. Perspektive der Krankenkassen auf Bedarfsdefinition und -steuerung · 2026 · Related
  11. Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes · Eleanor L. Ramos · 2023 · 259 citations · Cited by this paper
  12. Amyloidosen – Klassifikation, Diagnostik und Therapie · 2026 · Related
  13. Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes · Jeffrey P. Krischer · 2017 · 214 citations · Cited by this paper
  14. Mitteilungen der DGIM · 2026 · Related
  15. Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes · Michaela Waibel · 2023 · 191 citations · Cited by this paper
  16. Mitteilungen der DGIM · 2026 · Related
  17. Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes · Trevor Reichman · 2025 · 155 citations · Cited by this paper
  18. Praktischer Umgang mit dem arzneimittelinduzierten Long-QT-Syndrom · 2026 · Related
  19. ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes · Michael J. Haller · 2024 · 135 citations · Cited by this paper
  20. Computertomographie in der Kardiologie – Notwendigkeit und Entwicklungen · 2026 · Related
  21. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation · Sandra Hummel · 2023 · 121 citations · Cited by this paper
  22. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial · William E. Russell · 2023 · 106 citations · Cited by this paper
  23. Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression · Per‐Ola Carlsson · 2025 · 76 citations · Cited by this paper
  24. Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening · Andreas Weiß · 2022 · 74 citations · Cited by this paper
  25. The future of type 1 diabetes therapy · Anette‐Gabriele Ziegler · 2025 · 35 citations · Cited by this paper
  26. Genetic Engineering of Immune Evasive Stem Cell-Derived Islets · Sara Dutton Sackett · 2022 · 32 citations · Cited by this paper
  27. Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study · Erin L. Templeman · 2025 · 23 citations · Cited by this paper
  28. Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial · Chantal Mathieu · 2025 · 17 citations · Cited by this paper
  29. Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab · Chantal Mathieu · 2025 · 16 citations · Cited by this paper
  30. Scalable Bioreactor-based Suspension Approach to Generate Stem Cell–derived Islets From Healthy Donor-derived iPSCs · Kevin K. Verhoeff · 2024 · 15 citations · Cited by this paper
  31. Dysglycaemia definitions and progression to clinical type 1 diabetes in children with multiple islet autoantibodies · Sandra Hummel · 2024 · 15 citations · Cited by this paper
  32. Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial · Anette‐Gabriele Ziegler · 2025 · 14 citations · Cited by this paper
  33. Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled Trial · Anette‐Gabriele Ziegler · 2026 · 6 citations · Cited by this paper
  34. Früherkennung von Typ-1-Diabetes durch Inselautoantikörper-Screening – ein Positionspapier der Fr1daPlex-Projektleiter und -Schulungszentren, des BVKJ Bayern und PaedNetz Bayern e.V. · Peter Achenbach · 2024 · 5 citations · Cited by this paper
  35. Screening Children for Early-Stage Type 1 Diabetes · Christiane Winkler · 2026 · 3 citations · Cited by this paper
  36. Setting Expectations for Metabolic Outcomes of Total Pancreatectomy With Islet Autotransplantation: Validation From a Multicenter Cohort Study · Michael Roehrhoff Rickels · 2025 · 1 citation · Cited by this paper
  37. Untitled · Cited by this paper

Source: OpenAlex (CC0)